← SynDRA
OXATOMIDE
SynDRA canonical compound SYN0000668 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Primary target(s) | HRH1 |
| Mechanism of action | Histamine receptor antagonist |
| Indication | allergic rhinitis |
| Disease area | allergy |
All known targets
- HRH1
- CHRM1
- DRD3
- HTR2A
- HTR2B
- P2RX7
Mechanisms of action (all sources)
- Histamine receptor antagonist
- HRH1 ANTAGONIST
- Histamine H1 receptor antagonist
Drug classes
- Anti-Allergic Agents
- Anti-Asthmatic Agents
- Histamine Agents
- Histamine Antagonists
- Histamine H1 Antagonists
- Neurotransmitter Agents
- Respiratory System Agents
ATC classes
- R06A · ANTIHISTAMINES FOR SYSTEMIC USE
Cross-references
Synonyms
- KW-4354
- R 35 443
- celtect
- celtomide
- Oxatomida
- Celtect
- Cobiona
- Dasten
- NSC-309710
- R 35,443
- R-35443
- Tinset
- Oxatimide
- Oxatomidum
- Oxetal
- CBMicro_024634
- O 9387
- R35443
- Celtect (TN)
- McN-JR 35443
- Oxatomida [INN-Spanish]
- Oxatomide (tinset)
- Oxatomidum [INN-Latin]
- Oxatomide (JAN/USAN/INN)
- Oxatomide [USAN:BAN:INN:JAN]
- 1-(3-(4-(Diphenylmethyl)-1-piperazinyl)propyl)-1,3-dihydro-2H-benzimidazol-2-one
- 1-(3-(4-(Diphenylmethyl)-1-piperazinyl)propyl)-2-benzimidazolinone
- 1-[3-(4-Benzhydryl-piperazin-1-yl)-propyl]-1,3-dihydro-benzoimidazol-2-one
- 1-[3-[4-(Diphenylmethyl)-1-piperazinyl]propyl]-1,3-dihydro-2H-benzimidazol-2-one
- 1-[3-[4-(Diphenylmethyl)-1-piperazinyl]propyl]-2-benzimidazolinone
- 3-[3-(4-benzhydrylpiperazin-1-yl)propyl]-1H-benzimidazol-2-one
- R 35443
- J31IL9Z2EE
- NSC 309710
- DTXCID2025181
- CHEBI:31943
- RefChem:857075
- R06AE06
Look up OXATOMIDE in the interactive SynDRA portal →